Recently, evidence has been provided to indicate that differences in the gut microbiome composition among genetically different strains of mice confers differing capacities to digest dietary sugars, in turn altering the susceptibility of different mouse strains to metabolic disease through links between microbial metabolism and insulin secretion [25]. Here, INS is linked to metabolic disease.